Trevi Therapeutics TRVI
NASDAQ TRVI
$14.91 -0.40 (-2.61%)
At close: Nov 10, 2026 · 4:00 PM EST

Trevi Therapeutics (TRVI) Times Interest Earned (2018 - 2022)

Updated

Trevi Therapeutics' (TRVI) Times Interest Earned was -12881.00 for FY2024, compared with -86.76 in FY2023.

Analysis

Trevi Therapeutics (TRVI) Times Interest Earned (2018 - 2022) Analysis & Trends

Dating back to FY2018, Trevi Therapeutics' Times Interest Earned record includes 6 years.

  • The FY2024 figure ranks as the lowest annual Times Interest Earned in data going back to FY2018.
  • According to Business Quant data, Times Interest Earned came in at -86.76 in FY2023, -25.72 in FY2022, -27.02 in FY2021 and -71.25 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn -
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 28.50
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn -
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn -
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 10.28
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 7.27
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 5.68
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 12.87
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn -
10 Trevi Therapeutics 2.31 Bn 1.43 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -24.30
Sep 30, 2022 -28.78
Jun 30, 2022 -26.51
Mar 31, 2022 -23.26
Dec 31, 2021 -26.77
Sep 30, 2021 -22.93
Jun 30, 2021 -30.97
Mar 31, 2021 -27.51
Dec 31, 2020 -29.85
Sep 30, 2020 -48.95
Jun 30, 2018 -85.88
Mar 31, 2018 -25.54
API Access

Trevi Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=TRVI&period=max&api_key=YOUR_API_KEY